Characterization of novel phage Henuyfy11N: a potential therapeutic agent against extended-spectrum β-lactamase (ESBL)-producing <i>Escherichia coli</i>

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-04-27
DOI
https://doi.org/10.1128/spectrum.03253-25
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of novel phage Henuyfy11N: a potential therapeutic agent against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli

Li Wang, Zhigang Liu, Dongliang Qiao, Xinwei Zhang et al.
Microbiology Spectrum
Antibiotic Resistance in Bacteria
article

Characterization of novel phage Henuyfy11N: a potential therapeutic agent against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli

Li Wang, Zhigang Liu, Dongliang Qiao, Xinwei Zhang, Jiaqi He, Qiming Li
article en

Abstract

No abstract available for this paper.
Microbiology Spectrum
First Affiliated Hospital of Henan University of Science and Technology (CN), First Affiliated Hospital of Henan University of Traditional Chinese Medicine (CN), First Affiliated Hospital of Henan University (CN)
Health Commission of Henan Province, Science and Technology Department of Henan Province
Openalex Percentile: Top 8%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.